We are live on ! Find out more
MIM

MetLife Investment Management Portfolio holdings

AUM $19.6B
1-Year Est. Return 32.64%
This Fund
S&P 500
This Quarter Est. Return
+7.4%
1 Year Est. Return
+32.64%
3 Year Est. Return
+107.14%
5 Year Est. Return
+140.16%
10 Year Est. Return
AUM
$9.77B
AUM Growth
+$1.3B
Cap. Flow
+$764M
Cap. Flow %
7.83%
Top 10 Hldgs %
16.04%
Holding
2,679
New
514
Increased
162
Reduced
972
Closed
72

Sector Composition

Rank Sector Weight
1 Technology 16.73%
2 Financials 15.03%
3 Healthcare 13.46%
4 Industrials 10.27%
5 Consumer Discretionary 9.83%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SEND
1576
DELISTED
SendGrid, Inc.
SEND
$476K ﹤0.01%
+12,940
New +$408K
SMP icon
1577
Standard Motor Products
SMP
$870M
$474K ﹤0.01%
9,638
APOG icon
1578
Apogee Enterprises
APOG
$888M
$474K ﹤0.01%
11,475
-2,209
-16% -$107K
FINV
1579
FinVolution Group
FINV
$1.07B
$474K ﹤0.01%
+88,012
New +$457K
ROCC
1580
DELISTED
Ranger Oil Corporation Class A Common Stock
ROCC
$473K ﹤0.01%
5,878
ACH
1581
Accendra Health
ACH
$84.6M
$470K ﹤0.01%
28,475
MATV icon
1582
Mativ Holdings
MATV
$667M
$469K ﹤0.01%
12,254
-2,644
-18% -$110K
REGI
1583
DELISTED
Renewable Energy Group, Inc.
REGI
$469K ﹤0.01%
16,294
KMG
1584
DELISTED
KMG Chemicals Inc
KMG
$465K ﹤0.01%
6,159
PRDO icon
1585
Perdoceo Education
PRDO
$1.99B
$465K ﹤0.01%
31,150
CDNA icon
1586
CareDx
CDNA
$2.45B
$464K ﹤0.01%
16,080
PRFT
1587
DELISTED
Perficient Inc
PRFT
$463K ﹤0.01%
17,369
LNN icon
1588
Lindsay Corp
LNN
$1.17B
$461K ﹤0.01%
4,595
SRDX
1589
DELISTED
Surmodics
SRDX
$460K ﹤0.01%
6,159
OSG
1590
Octave Specialty Group
OSG
$212M
$458K ﹤0.01%
22,444
BHVN
1591
DELISTED
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
$457K ﹤0.01%
+12,167
New +$448K
WT icon
1592
WisdomTree
WT
$3.44B
$455K ﹤0.01%
53,688
DNLI icon
1593
Denali Therapeutics
DNLI
$3.97B
$455K ﹤0.01%
+20,915
New +$346K
UHT
1594
Universal Health Realty Income Trust
UHT
$573M
$455K ﹤0.01%
6,109
TCBK icon
1595
TriCo Bancshares
TCBK
$1.86B
$453K ﹤0.01%
11,734
+1,947
+20% +$75.3K
SPNT icon
1596
SiriusPoint
SPNT
$2.7B
$452K ﹤0.01%
+34,789
New +$454K
HTO
1597
H2O America
HTO
$2.65B
$452K ﹤0.01%
7,394
PRO
1598
DELISTED
PROS Holdings
PRO
$452K ﹤0.01%
12,910
ATRO icon
1599
Astronics
ATRO
$4.57B
$452K ﹤0.01%
14,327
NTLA icon
1600
Intellia Therapeutics
NTLA
$1.66B
$451K ﹤0.01%
15,741

Similar funds

MetLife Investment Management's Q3 2018 Portfolio in Review

As of Q3 2018, MetLife Investment Management held 2,679 positions worth $9.77B, up 15% from $8.47B the previous quarter. Its ten largest holdings account for 16% of the portfolio.

MetLife Investment Management deployed $764M of net new capital in Q3 2018, opening 514 new positions and adding to 162 existing holdings. Its largest new stake was Alphabet (Google) Class C: 1,791,300 shares worth $107M.

By sector, the portfolio is most concentrated in Technology at 17% of assets, down from 17% a quarter earlier, followed by Financials and Healthcare.

On the sell side, the largest reduction was Apple, an estimated $23.3M trimmed.

  • MetLife Investment Management's largest Q3 2018 buy was Alphabet (Google) Class C: 1,791,300 shares worth $107M.
  • MetLife Investment Management added most to iShares Core US Aggregate Bond ETF in Q3 2018, an estimated $98.5M increase.
  • MetLife Investment Management's biggest Q3 2018 reduction was Apple, cutting an estimated $23.3M.
  • MetLife Investment Management fully exited Wgl Holdings in Q3 2018, selling an estimated $4.93M.
  • MetLife Investment Management's ten largest holdings make up 16% of its $9.77B portfolio in Q3 2018.
  • MetLife Investment Management opened 514 new positions and closed 72 in Q3 2018.
  • MetLife Investment Management's portfolio value rose 15% quarter-over-quarter to $9.77B.

Based on MetLife Investment Management's 13F filing for Q3 2018, filed 14 Nov 2018.